Effectiveness of Homoeopathic medicine Arundo 30C in allergic rhinitis

CATALYTIC EFFECT OF ARUNDO 30 IN ALLERGIC RHINITIS PATIENTS UNDER CONSTITUTIONAL TREATMENT – A PROSPECTIVE QUASI EXPERIMENTAL STUDY - NIL

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/09/057838

Enrollment

Registered

2023-09-19

Start date

Unknown

Completion date

Unknown

Last updated

2023-10-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J309- Allergic rhinitis, unspecified

Interventions

Intervention1: Arundo 30C: Arundo 30C in globules ( 3 pills 3 times daily )along with constitutional medicines in 200C or 1M potency according to the susceptibility of the patient as monthly doses- b

Eligibility

Inclusion criteria

Inclusion criteria: Inclusion criteria: _ 1. Patients with clinical presentation of allergic rhinitis and raised AEC value 2. Patients of age 18-70 3. All gender categories

Exclusion criteria

Exclusion criteria: 1. patients with nasal polyps, asthma, or other chronic respiratory diseases 2. Immunocompromised individuals

Design outcomes

Primary

Measure	Time frame
1.To evaluate the catalytic potential of Arundo 30C in allergic rhinitis patients taking homeopathic constitutional medicines 2.To evaluate the effectiveness of Arundo 30C by comparing the difference in changes in total nasal symptom score & absolute eosinophil count in the study group and control group before and after treatment. Timepoint: Base line and three months	—

Secondary

Measure	Time frame
To compare the improvement in the quality of life of patients in both study & control groupsTimepoint: base line & three months	—

Countries

India

Contacts

Public ContactAparna M Nair

Kerala University of health sciences

cnnisha0703@gmail.com9809320091

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026